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The skin forms a natural barrier that protects underlying tissue; once the skin barrier is broken, wound repair is induced by a metic-
ulously orchestrated host response.1 Nonhealing 
wounds represent a major health care burden and 
affect approximately 1 percent of the population,2 
and the leading threat to all wounds is infection 
by microorganisms.3 Chemical antiseptics are the 
favored method in clinical routine because of 
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Background: Although chemical antiseptics are the most basic measure to 
control wound infection and frequently come into contact with subcutaneous 
adipose tissue, no studies have evaluated their toxicity on adipose tissue and 
its cell fractions. In the present study, the effects of five different antiseptics 
on adipose-derived stem cells were evaluated.
Methods: Human adipose-derived stem cells were harvested from healthy 
donors. Adipose-derived stem cell viability was measured after treatment 
with different concentrations of antiseptics over 5 days. Furthermore, the 
effect on the proliferation, adipogenic differentiation, and apoptosis/ne-
crosis of adipose-derived stem cells was analyzed. Finally, the mRNA expres-
sion of the stem cell markers CD29, CD34, CD73, CD90, and CD105 was 
detected.
Results: Octenisept and Betaisodona significantly reduced cell proliferation 
and differentiation and led to considerable adipose-derived stem cell necrosis. 
Octenisept decreased stem cell viability at the lowest concentrations tested, 
and all stem cell markers were down-regulated by Octeniseptr and Betaiso-
dona. Lavasept and Prontosan both led to reduced stem cell viability, prolif-
eration, and differentiation, and increased apoptosis/necrosis, although the 
effects were less pronounced compared with Octenisept and Betaisodona. 
Adipose-derived stem cells survived treatment with mafenide acetate even at 
high concentrations, and mafenide acetate showed minimal negative effects 
on their proliferation, adipogenic differentiation, cell death, and stem cell 
marker expression.
Conclusions: Mafenide acetate may be regarded as a feasible antiseptic for the 
treatment of wounds with exposed adipose tissue because of its low adipose-
derived stem cell toxicity. Lavasept and Prontosan are possible alternatives to 
mafenide acetate. Octenisept and Betaisodona, by contrast, may be used only 
in highly diluted solutions. (Plast. Reconstr. Surg. 139: 625, 2017.)
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their effectiveness, simple applicability, and low 
costs.4,5
To date, most authors have limited investiga-
tion of the toxicity of antiseptics to skin cells (i.e., 
keratinocytes and fibroblasts) and adapted the 
concentrations of the reagents accordingly.6–10 
With the exception of superficial wounds, how-
ever, the tissue layers underneath the skin also are 
affected and prone to bacterial contamination. 
Subcutaneous adipose tissue actively participates 
in wound repair by the delivery of cytokines and 
the differentiation of progenitor cells.11–16 Adi-
pose tissue has been discovered to be a rich source 
of adipose-derived stem cells, which possess con-
siderable regenerative potential17 and play a well-
documented beneficial role in wound repair.2,18
Adipose tissue frequently comes into contact 
with chemical antiseptics during the treatment of 
plastic surgical patients, especially during surgical 
preparation of open or infected wounds that entails 
direct contact. Additional scenarios are the rinsing 
of wounds and antiseptic dressings for the treatment 
of critical wounds. However, no studies have exam-
ined possible toxic effects of antiseptics on adipose-
derived stem cells. In the present study, we measured 
the effect of five commercially available antiseptics 
on the viability, proliferation, cell death, expression 
of stem cell markers, and differentiation of cultured 
adipose-derived stem cells with the goal of iden-
tifying auspicious antiseptics for the treatment of 
wounds with exposure of adipose tissue.
PATIENTS AND METHODS 
Human Samples
Adipose tissue was harvested from 13 healthy 
patients (six men and seven women), with a mean 
age 38.7 ± 4.4 years, undergoing surgery at the 
Department of Plastic and Reconstructive Surgery, 
Hand Surgery–Burn Center at the University Hos-
pital in Aachen. The study outline is illustrated in 
Figure 1. The study was approved by the regional 
ethics committee (EK163/07) and all experi-
ments were conducted in compliance with the 
Fig. 1. Schematic diagram of the experimental design. ASCs, adipose-derived stem cells; ELISA, enzyme-linked immunosor-
bent assay; RT-PCR, real-time polymerase chain reaction.
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principles outlined in the Declaration of Helsinki. 
Samples were not mixed and each experiment was 
repeated once. Each of the repeated experiments 
was performed in duplicate and the statistical 
analysis is based on the mean of the independent 
repeated experiments.
Antiseptics Used 
The antiseptics Betaisodona, Lavasept, 
mafenide acetate, Octenisept, and Prontosan 
were used in our study (Table 1).
Isolation of Adipose-Derived Stem Cells
Lipoaspirates were harvested according to the 
Coleman protocol.19 Adipose-derived stem cells 
were harvested as described earlier.20
Treatment with Antiseptics and Measurement of 
Adipose-Derived Stem Cell Viability
Cell proliferation was measured by the ala-
marBlue assay (AbDSerotec, Oxford, United 
Kingdom) following the manufacturer’s guide-
lines. Adipose-derived stem cells were cultured in 
24-well plates overnight. The following day, cell 
viability was measured by alamarBlue. This value 
was set as 100 percent and served as the refer-
ence for all following measurements. After the 
measurement, the medium was removed and the 
cells were incubated for 5 minutes with antiseptics 
in the following concentrations: 1, 2.5, 5, 7.5, 10, 
and 25% of the original concentration provided 
by the manufacturer. We also treated cells with 
undiluted saline (0.9% sodium chloride). Growth 
medium served as a negative control. Cell viability 
was examined after 1, 3, and 5 days.
Hoechst 33342 Staining
Five days after treatment of adipose-derived stem 
cells with antiseptics, saline, and medium, adipose-
derived stem cells were stained with Hoechst 33342 
and cells were fixed with 4% paraformaldehyde. Flu-
orescence microscopy was performed by an inverted 
phase contrast microscope (Leica DMI4000 B; Leica 
Microsystems, Buffalo Grove, Ill.).
Measurement of Adipose-Derived Stem Cell 
Proliferation by Bromodeoxyuridine Enzyme-
Linked Immunosorbent Assay
Proliferation of adipose-derived stem cells 
was analyzed by the CytoSelect Bromodeoxyuri-
dine Cell Proliferation ELISA Kit (Cell Biolabs, 
Inc., San Diego, Calif.) according to the manu-
facturer’s instructions in 96-well plates. Cells were 
treated with 7.5% antiseptics, saline, and medium 
for 5 minutes.
Measurement of Apoptosis and Necrosis
Necrosis and apoptosis were detected with the 
Pacific Blue Annexin V Apoptosis Detection Kit 
(Biolegend, San Diego, Calif.). Adipose-derived 
stem cells were treated with antiseptics at a con-
centration of 7.5%, saline, and medium for 5 min-
utes. Cells were stained with Pacific Blue–labeled 
annexin V and 7-aminoactinomycin D. Stained 
cells were evaluated by flow cytometry on a LSR II 
cytometer (BD Biosciences, San Jose, Calif.).
Table 1. Ingredients and Antimicrobial Efficacy of the Antiseptics Used
Name and Manufacturer Ingredients Antimicrobial Efficacy
Betaisodona
(Mundipharma Research, Limburg, 
Germany)
100 ml of the solution contains 10 g of 
povidone-iodine complex and 11% 
available iodine.
Viruses, Gram-positive and Gram-negative 
bacteria, tubercle bacilli, fungi, protozoa, 
methicillin-resistant Staphylococcus aureus
Lavasept concentrate
(B. Braun Melsungen AG, Melsungen, 
Germany)
100 ml of the concentrate contains 20 g 
of polyhexanide and 1 g of polyethyl-
ene glycol 4000. The concentrate was 
diluted to a polyhexanide concentra-
tion of 0.04% as recommended by the 
manufacturer.
Fungi and bacteria including staphylococci, 
enterococci, Pseudomonas aeruginosa, 
intestinal bacterial such as Escherichia coli
Mafenide acetate
(Fagron GmbH & Co. KG, Barsbüttel, 
Germany)
Powder was diluted in 0.9% sodium 
chloride to a final concentration of 5% 
mafenide acetate as recommended by 
the manufacturer.
Gram-negative and Gram-positive bacteria, 
Pseudomonas aeruginosa, some anaerobic 
organisms, molds
Octenisept
(Schülke & Mayr GmbH, Norderstedt, 
Germany)
100 ml of the solution contains 0.1 g of 
octenidine dihydrochloride and 2 g of 
2-phenoxyethanol.
Chlamydia, mycoplasma, fungi, yeasts, pro-
tozoa, viruses (herpes simplex, hepatitis 
B virus, hepatitis C virus, human immu-
nodeficiency virus), and importantly also 
methicillin-resistant Staphylococcus aureus
Prontosan
(B. Braun Melsungen AG, Melsungen, 
Germany)
Solution contains 0.1% undecylenamido-
propyl betaine and 0.1% polyhexanide.
Fungi and bacteria including staphylococci, 
enterococci, Pseudomonas aeruginosa, 
intestinal bacterial such as Escherichia coli
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Isolation of mRNA, Reverse Transcription, and 
Real-Time Polymerase Chain Reaction
Messenger RNA from whole adipose tis-
sue for real-time polymerase chain reaction 
was prepared by the RNeasy Mini Kit (Qiagen 
NV, Venlo, The Netherlands) and reverse tran-
scription into cDNA was performed by the First 
Strand cDNA Synthesis Kit (Thermo Fisher 
Scientific, Inc., Waltham, Mass.) following the 
manufacturers’ instructions. Quantitative real-
time polymerase chain reaction was carried out 
with the iTaq Universal SYBR Green Supermix 
(Bio-Rad Laboratories, Inc., Irvine, Calif.) on 
a C1000TM Thermal Cycler (Bio-Rad). Primers 
used in the assay are listed in Table 2. Data were 
normalized to the housekeeping gene glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH). 
Changes in gene expression were compared to 
adipose-derived stem cells treated with growth 
medium. Treatment with 1-µM staurosporine 
and 500-µM hydrogen peroxide (both from 
Sigma Aldrich Chemie GmbH, Taufkirchen, 
Germany) served as apoptosis and necrosis 
controls.
Adipose-Derived Stem Cell Differentiation and 
Oil Red O Staining
Adipogenic differentiation of cultured 
adipose-derived stem cells was induced as 
reported earlier.21 Over the whole differentiation 
period, medium was supplemented with 0.05% 
antiseptics/saline.
Statistical Analysis
The software Prism, version 5.03 (Graph-
Pad Software, Inc., La Jolla, Calif.) was used for 
data analysis. One-way analysis of variance was 
performed for multiple comparisons. Two-way 
repeated measures analysis of variance with a 
post hoc multiple comparison test (Bonfer-
roni) was used for analyzing adipose-derived 
stem cell viability over time. Data are shown as 
means ± SEM. A value of p < 0.05 was considered 
significant.
RESULTS
Antiseptics Influence the Viability of  
Adipose-Derived Stem Cells
The viability of adipose-derived stem cells 
treated by antiseptics was measured by the ala-
marBlue assay (Fig. 2). For all antiseptics, a 
dose-dependent reduction of cell viability was 
observed. Octenisept showed the highest cell 
toxicity. Adipose-derived stem cells treated 
with only 1% Octenisept did not recover com-
pletely. A 2.5% Octenisept solution resulted 
in complete cell death (2.5, 5, and 10%). [See 
Figure, Supplemental Digital Content 1, which 
shows the influence of antiseptics on the via-
bility of adipose-derived stem cells. Cultured 
adipose-derived stem cells were treated with 
2.5% (above), 5% (center), and 10% (below) solu-
tions of Octenisept, Betaisodona, Prontosan, 
Lavasept, mafenide acetate, or normal saline. 
Growth medium served as a control. The viabil-
ity of adipose-derived stem cells was evaluated 
by the alamarBlue assay after 1, 3, and 5 days. 
The viability of adipose-derived stem cells before 
treatment was set as 100 percent. Data are pre-
sented in means ± SEM. Significant differences 
when compared to other groups are indicated 
by letters in lowercase. Normal (not bold/itali-
cized), p < 0.05; bold, p < 0.01; bold and italicized, 
p < 0.001; o, Octenisept; b, Betaisodona; p, Pron-
tosan; l, Lavasept; m, mafenide acetate; s, saline; 
g, growth medium, http://links.lww.com/PRS/
C65.] Cell viability was not significantly reduced 
in adipose-derived stem cells treated with 1% 
and 2.5% Betaisodona, whereas a 5% solution 
led to marked cytotoxicity. Similarly, adipose-
derived stem cells treated with 5% Prontosan 
recovered from the initial exposure, whereas 
concentrations greater than or equal to 7.5% 
led to irreversible cell death. Lavasept did not 
show significant cytotoxicity at concentrations 
less than or equal to 5%. A solution of 7.5% 
and 10% caused a reduction of adipose-derived 
stem cell viability but cells still recovered. Only 
a 25% solution of Lavasept led to the complete 
Table 2. Quantitative Real-Time Polymerase Chain Reaction Primers







GAPDH, glyceraldehyde 3-phosphate dehydrogenase. 
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Fig. 2.   The influence of antiseptics on the viability of adipose-derived stem cells. Cultured adipose-derived stem cells were treated 
with (above) 1%, (center) 7.5%, and (below) 25% solutions of Octenisept, Betaisodona, Prontosan, Lavasept, mafenide, or normal
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death of adipose-derived stem cells. As the only 
exception, adipose-derived stem cells survived 
the treatment with the maximum concentration 
of 25% of mafenide acetate. When compared to 
growth medium, however, adipose-derived stem 
cells treated with mafenide acetate had signifi-
cantly decreased viability at 10% and 25%. Saline 
only had minimal effect on keratinocyte viability. 
Our alamarBlue measurements were confirmed 
by Hoechst staining at day 5, and representative 
images of adipose-derived stem cells treated with 
7.5% of the antiseptic/saline/growth medium 
are shown in Figure 3).
Antiseptics Influence the Proliferation of 
Adipose-Derived Stem Cells
Cell proliferation was evaluated by the bro-
modeoxyuridine assay (Fig. 4, above, left). Because 
a concentration of 7.5% showed the most remark-
able difference in adipose-derived stem cell via-
bility between the tested antiseptics, we selected 
this specific concentration for further study, 
including the bromodeoxyuridine incorpora-
tion assay. Similar to the alamarBlue assay, cell 
proliferation was reduced by all antiseptics and 
saline. Although saline, Lavasept, and mafenide 
acetate led to a modest decrease in proliferation, 
Prontosan, Betaisodona, and Octenisept reduced 
adipose-derived stem cell proliferation by more 
than 70 percent.
Antiseptics Influence the Apoptosis and Necrosis 
of Adipose-Derived Stem Cells
We investigated the effect of antiseptics on 
cell death by the annexin V assay, which allows for 
the distinction between early/late apoptosis and 
necrosis (Fig. 4, above, right and Table 3). We com-
pared the ratio between necrosis and apoptosis 
(sum of early and late apoptosis) and calculated 
the difference in necrosis between the antiseptics 
(Table 3). All antiseptics caused increased adipose-
derived stem cell necrosis compared with growth 
medium. Octenisept and Betaisodona both led to 
cell death mainly by necrosis. Prontosan resulted 
in a higher degree of cell death compared with 
Lavasept, mafenide acetate, and saline, which 
all induced comparable rates of necrosis and 
apoptosis.
Antiseptics Influence the Expression of Stem Cell 
Markers of Adipose-Derived Stem Cells
CD29, CD34, CD73, CD90, and CD105 mRNA 
expression was examined by qualitative real-time 
polymerase chain reaction after treatment with 
7.5% solutions of each antiseptic, saline, medium, 
staurosporine, hydrogen peroxide, and ultra-
violet light (Fig. 5). Although the expression of 
none of the markers was changed by saline, Betai-
sodona caused a significant down-regulation of 
all five stem cell markers (CD34 was not detect-
able). Octenisept also led to a down-regulation 
of all markers except for CD105. Lavasept and 
Prontosan showed a distinctive down-regulation 
of CD34 and moderate down-regulation of CD29. 
Mafenide acetate was the only antiseptic that did 
not influence the expression of any stem cell 
markers significantly. Staurosporine reduced only 
CD105 expression, whereas hydrogen peroxide 
reduced all stem cell markers.
Antiseptics Influence the Adipogenic 
Differentiation of Adipose-Derived Stem Cells
The adipogenic differentiation potential of 
adipose-derived stem cells was examined by Oil 
Red staining (Fig. 4, below). The low concen-
tration of 0.05% of antiseptics did not lead to 
increased cell death as confirmed by the alamar-
Blue assay. All of the tested antiseptics reduced 
the adipogenic differentiation of adipose-derived 
stem cells, whereas saline did not have a signifi-
cant effect. Under Lavasept, mafenide acetate, 
and Prontosan treatment, adipogenic differentia-
tion was reduced by almost 40 percent, whereas 
Betaisodona and Octenisept led to a reduction of 
almost 80 percent.
DISCUSSION
Adipose-derived stem cells are pluripotent 
mesenchymal stem cells located in the adipose tis-
sue and are competent to self-renew, proliferate, 
and differentiate into multiple cell lines.17 Adi-
pose-derived stem cells promote wound repair by 
differentiation into keratinocytes and fibroblasts, 
secretion of growth factors, and stimulation of 
angiogenesis.14,16 Because of high yield and easy, safe 
harvest procedures, adipose-derived stem cells rep-
resent a true alternative to bone marrow–derived 
stem cells.22 Improved wound repair by treatment 
Fig. 2. (Continued). saline. Growth medium served as a control. 
The viability of adipose-derived stem cells was evaluated by the 
alamarBlue assay after 1, 3, and 5 days. The viability of adipose-
derived stem cells before treatment was set as 100 percent. Data 
are presented in means ± SEM. Significant differences when 
compared to other groups are indicated by letters in lower case. 
Normal (not bold/italicized), p < 0.05; bold, p < 0.01; bold and 
italicized, p < 0.001; o, Octenisept; b, Betaisodona; p, Prontosan; l: 
Lavasept; m, mafenide acetate; s, saline; g, growth medium. 
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with adipose-derived stem cells has been repeatedly 
reported in a multitude of clinical studies, and inter-
est in the regenerative properties of adipose-derived 
stem cells continues to increase.2 In this study, we 
have examined the effect of different chemical 
antiseptics on the viability, proliferation, cell death, 
expression of stem cell markers, and adipogenic dif-
ferentiation of adipose-derived stem cells in vitro.
Fig. 3. After the fifth day of treatment with a 7.5% solution of antiseptics, adipose-
derived stem cells were stained by Hoechst 33342. Hoechst 33342 staining of adipose-
derived stem cells treated with Octenisept, Betaisodona, Prontosan, Lavasept, Mafenide, 
normal saline, or growth medium.
Copyright © 2017 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited. 
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Octenisept is a standard antiseptic used in 
Europe, and is composed of the antiseptic agents 
octenidine dihydrochloride and phenoxyetha-
nol. However, serositis after peritoneal lavage, 
severe subcutaneous edema with fatty tissue 
necrosis in pediatric patients, and chronic 
soft-tissue inflammation combined with tissue 
necrosis of the hand have been reported with 
its use.23–27 As a result, the manufacturer issued 
a warning for the use of Octenisept for the irri-
gation of deep wounds with high force. In our 
experiments, Octenisept reduced the viability of 
Fig. 4. The influence of antiseptics on proliferation, cell death, and adipogenic differentiation of adipose-
derived stem cells. Adipose-derived stem cells were treated with a 7.5% solution of Octenisept, Betaisodona, 
Prontosan, Lavasept, mafenide acetate, or normal saline. Growth medium served as a control. (Above, left) Adi-
pose-derived stem cell proliferation was measured by the bromodeoxyuridine assay. (Above, right) Cell death 
was evaluated by the annexin V assay, which allows a division of cell death into necrosis (7-aminoactinomycin 
D–positive/annexin V–negative), early apoptosis (7-aminoactinomycin D–positive/annexin V–positive), and 
late apoptosis (7-aminoactinomycin D–positive/annexin V–positive). The mean ± SEM percentages of necrosis, 
early apoptosis, and late apoptosis are shown. Asterisks mark significant differences between necrosis versus 
apoptosis (early and late apoptosis). (Below) Adipose-derived stem cell differentiation was analyzed by Oil Red 
staining after inducing adipogenic differentiation of adipose-derived stem cells by differentiation that was 
supplemented with 0.05% solutions of the antiseptics. For above, left and below, data are presented as means ± 
SEM. Significant differences when compared to other groups are indicated by letters in lowercase. Normal (not 
bold/italicized), p < 0.05; bold, p < 0.01; bold and italicized, p < 0.001; o, Octenisept; b, Betaisodona; p, Prontosan; 
l, Lavasept; m, mafenide acetate; s, saline; g, growth medium; ASC, adipose-derived stem cell.
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adipose-derived stem cells even when diluted to 
a 1% solution, whereas the other tested antisep-
tics showed marginal to no reduction of viability. 
Adipose-derived stem cell viability is dependent 
on cell proliferation, which also was significantly 
reduced by Octenisept. In contrast to apoptosis, 
which is a well-controlled form of cell death that 
may be inhibited by certain measures, Octenisept 
induces necrosis, an irreversible and therefore 
more detrimental form of cell death.28,29 Necro-
sis is followed by an inflammatory response, 
which may further perpetuate the critical condi-
tion of wound repair disorders.30 Octenisept also 
reduced the expression of the stem cell markers 
CD29, CD34, CD90, and CD105. The Interna-
tional Society for Cellular Therapy defined the 
minimal criteria of cultured mesenchymal stem 
cells, among others, by the expression of CD73, 
CD90, and CD105.31 CD29 and CD34 are addi-
tional surface markers that are used consistently 
to characterize mesenchymal stem cells.32,33 Stau-
rosporine is a well-investigated inducer of apop-
tosis,34 whereas high concentrations of hydrogen 
peroxide induce necrosis.35 As the pattern of 
stem cell marker reduction by Octenisept was 
similar to that of hydrogen peroxide, necrosis 
may be the most feasible explanation for Octeni-
sept-related stem cell marker reduction. The 
capability of adipogenic differentiation, which 
is a hallmark of adipose-derived stem cells and 
an important contributor to tissue regeneration, 
was significantly reduced by Octenisept and may 
be another deleterious factor associated with its 
use.17,36
Povidone-iodine is the main antiseptic reagent 
of Betaisodona.37 For irrigation, cleansing, and 
bathing, the manufacturer recommends dilutions 
of 1:2 to 1:100. Betaisodona showed the second 
highest reduction of adipose-derived stem cell 
viability after Octenisept. Betaisodona further 
reduced adipose-derived stem cell proliferation 
and differentiation. Betaisodona led to a marked 
decrease in the expression of all five stem cell 
markers, which may primarily reflect necrosis of 
adipose-derived stem cells.
Prontosan and Lavasept are both antiseptic 
solutions containing the antimicrobial agent 
polyhexanide.38 Prontosan wound irrigation 
solution is a ready-to-use antiseptic, whereas 
Lavasept is distributed as a liquid concentrate 
and its use is recommended in a 0.2% solution. 
The cytotoxicity of Prontosan and Lavasept was 
significantly weaker than that of Octenisept 
and Betaisodona. The stronger reduction of 
adipose-derived stem cell viability and prolif-
eration, and the increase of necrosis, by Pronto-
san compared with Lavasept may be explained 
by the higher initial concentration, which was 
0.1% polyhexanide compared with 0.04% poly-
hexanide in Lavasept. Importantly, CD34+ adi-
pose-derived stem cells are described as being 
more proliferative and possessing higher stem-
ness.33 Both antiseptics reduced the expression 
of CD34. As neither staurosporine nor hydrogen 
peroxide led to a similar isolated CD34 reduc-
tion, this effect may present a polyhexanide-
specific effect.
Mafenide acetate is a short-acting sulfon-
amide that is provided as a powder. It read-
ily penetrates burn eschar, where it retains its 
antimicrobial activity even in an acidic envi-
ronment. Mafenide acetate showed the mild-
est effect on the viability, proliferation, and 
cell death of adipose-derived stem cells in our 
study. Adipose-derived stem cells survived treat-
ment with mafenide acetate even at a concen-
tration of 10% and 25%. In addition, none of 
the stem cell markers were significantly altered 
by mafenide acetate. Since its first use in World 
War II, mafenide acetate’s primary indication 
has been the antibacterial control of burn-
related wounds/mesh grafts. However, in some 
Table 3. Comparison of Necrosis between the Antiseptics, Saline, and Growth Medium*
 Octenisept Betaisodona Prontosan Lavasept Mafenide Acetate Saline Medium
Octenisept  NS ‡ ‡ ‡ ‡ ‡
Betaisodona ‡  ‡ ‡ ‡ ‡ ‡
Prontosan ‡ NS  NS NS † ‡
Lavasept † ‡ NS  NS NS †
Mafenide acetate † ‡ NS NS  NS †
Saline ns ‡ † NS NS  †
Medium ‡ ‡ ‡ † † NS  
NS, not significant.
*The necrosis of adipose-derived stem cells was measured by the annexin V assay. Significant differences in necrotic cells necrosis (7-aminoac-
tinomycin D–positive/annexin V–negative) are marked.
†p < 0.05.
‡p < 0.001.
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Fig. 5. Expression of stem cell markers after treatment with antiseptics. After treatment of cultured adi-
pose-derived stem cells with Octenisept, Betaisodona, Prontosan, Lavasept, Mafenide, or normal saline, the 
expression of different stem cell markers was analyzed by qualitative real-time polymerase chain reaction. 
Growth medium served as a negative control. Staurosporine served as a control for apoptosis, whereas 
hydrogen peroxide served as a control for necrosis. Expression of mRNA of (above, left) CD29, (above, right) 
CD34, (center, left) CD73, (center, right) CD90, and (below) CD105 is depicted. Data are presented as means ± 
SEM. Significant differences when compared to other groups are indicated by letters in lowercase. Normal 
(not bold/italicized), p < 0.05; bold, p < 0.01; bold and italicized, p < 0.001; o, Octenisept; b, Betaisodona; p, 
Prontosan; l, Lavasept; m, mafenide; s, saline; g, growth medium; t, staurosporine; h, hydrogen peroxide.
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cases, off-label application of mafenide acetate 
for the treatment of wounds not related to burns 
is possible.39,40 Bennett et al. demonstrated that 
mafenide acetate was a highly effective antiseptic 
in a porcine wound model.41 Other studies sup-
port the beneficial effect of mafenide acetate on 
partial-thickness and full-thickness wounds.42,43 
In chronic wounds reaching the subcutaneous 
tissue and particularly Pseudomonas aeruginosa–
colonized wounds, mafenide acetate may repre-
sent a genuine alternative to other antiseptics. 
Drawbacks of mafenide acetate, however, are its 
high costs and a requirement for use within 48 
hours once the powder is reconstituted.44
We also examined the effect of saline on adipose-
derived stem cell viability. Plain saline is commonly 
used in clinical practice to irrigate wounds, either 
pure or as a diluent for antibiotics and antiseptics. 
We have shown that treatment of adipose-derived 
stem cells with pure saline led to a slight reduc-
tion of cell viability and proliferation, and a small 
increase of cell death, but did not influence stem 
cell marker expression and adipogenic differentia-
tion. However, its general effectiveness in the pre-
vention of infections is still the subject of debate.45 
In the context of adipose tissue and adipose-derived 
stem cell harvest for aesthetic or reconstructive pur-
poses, the use of saline (e.g., to rinse adipose tissue) 
may be regarded as rather uncritical.
Aside from the toxicity of antiseptics, the anti-
microbial potency is pivotal. Interestingly, Müller 
and Kramer found that Octenisept had superior 
efficacy against Escherichia coli and Staphylococcus 
aureus compared with Lavasept, and Betaisodona 
showed the weakest antimicrobial efficiency.10 
Hirsch et al. also identified Betaisodona as the 
least effective antiseptic against S. aureus, Entero-
bacter faecalis, P. aeruginosa, and E. coli compared 
with Octenisept, Prontosan, and Lavasept, all 
of which showed similar efficiency.6 Rode et al. 
studied the antimicrobial efficiency of mafenide 
acetate and Betaisodona ointment in rats infected 
with P. aeruginosa and found that mafenide acetate 
was superior to Betaisodona.46 Bennett et al. also 
reported higher efficiency of mafenide acetate 
than povidone-iodine–based antiseptics in a por-
cine burn model.41 Collectively, Betaisodona may 
be the least effective antiseptic, as it shows high 
adipose-derived stem cell toxicity and relatively 
low antimicrobial efficiency. Octenisept, by con-
trast, shows high adipose-derived stem cell toxicity 
but also high germicidal activity at low concentra-
tions so that a higher dilution may be advocated.
Not only adipose-derived stem cells but also 
other cells such as keratinocytes and fibroblasts 
contribute to wound repair. In keratinocytes, 
Betaisodona and Octenisept showed high cyto-
toxicity and significant reduction of proliferation, 
whereas Prontosan and Lavasept exerted only 
minor effects.6 For fibroblasts, controversial results 
were reported. Müller and Kramer observed the 
highest cytotoxicity with Octenisept, followed by 
Lavasept and Betaisodona,10 wheras Hirsch et al. 
showed substantial cytotoxic and antiprolifera-
tive effects of Betaisodona and Octenisept but no 
such effects of Prontosan and Lavasept.6 Higher 
cytotoxic effects on chondrocytes were observed 
for povidone-iodine–based antiseptics compared 
with Lavasept.47 Consequently, Octenisept and 
povidone-iodine–based antiseptics appear to be 
more detrimental to cells than polyhexanide-
based antiseptics.
We have to acknowledge some limitations 
of our study. We have to concede that our data 
were collected from in vitro experiments. In 
vitro experiments are surely a valuable approach 
and a starting point for unraveling underlying 
mechanisms. Nonetheless, the effects of an in 
vivo environment where surrounding cells, extra-
cellular matrix, active perfusion, and additional 
physiologic processes may facilitate clearance of 
antiseptics and counterregulate toxic effects are 
neglected. To translate our results into clinical 
practice (i.e., the treatment of deep wounds), 
additional studies are needed. Different in vivo 
wound models48 may be used to examine the 
systemic influences. The harvest and analysis of 
adipose tissue from patients treated with the dif-
ferent antiseptics may deliver more applicable 
data and better reflect the in vivo effect of anti-
septics on wounds and may therefore be consid-
ered in future studies.
CONCLUSIONS
Mafenide acetate exerted the mildest toxic 
effects on human adipose-derived stem cells. Lava-
sept and Prontosan showed moderate toxicity and 
may be regarded as an alternative to mafenide 
acetate. Octenisept and Betaisodona, in contrast, 
reduced adipose-derived stem cell viability, prolifer-
ation, and differentiation significantly and caused 
considerable adipose-derived stem cell necrosis.
Bong-Sung Kim, M.D.
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